[{"address1": "Bay & Deveaux Streets", "address2": "2nd Floor", "city": "Nassau", "country": "Bahamas", "phone": "800 936 9669", "fax": "514 332 2227", "website": "https://nymox.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of products for the aging population in Canada, the United States, and Europe. Its lead drug candidate is Fexapotide Triflutate (NX-1207) for the treatment of benign prostatic hyperplasia and low grade localized prostate cancer, as well as hepatocellular carcinoma. The company also offers NicAlert for detecting smoking status; and TobacAlert for detecting second-hand smoke exposure. In addition, it develops drugs for the treatment of Alzheimer's disease. The company was founded in 1989 and is headquartered in Nassau, Bahamas.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Paul  Averback DABP, M.D.", "age": 72, "title": "Founder, Chairman, CEO & President", "yearBorn": 1951, "fiscalYear": 2023, "totalPay": 157000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Lin  Dodd", "title": "QA and Compliance Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Patrick  Doody", "age": 60, "title": "VP, General Counsel & Director", "yearBorn": 1963, "fiscalYear": 2023, "totalPay": 32868, "exercisedValue": 0, "unexercisedValue": 26250}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.07, "open": 0.08, "dayLow": 0.07, "dayHigh": 0.08, "regularMarketPreviousClose": 0.07, "regularMarketOpen": 0.08, "regularMarketDayLow": 0.07, "regularMarketDayHigh": 0.08, "beta": 9.083, "volume": 12830, "regularMarketVolume": 12830, "averageVolume": 17533, "averageVolume10days": 27572, "averageDailyVolume10Day": 27572, "bid": 0.07, "ask": 0.13, "marketCap": 13095613, "fiftyTwoWeekLow": 0.0001, "fiftyTwoWeekHigh": 1.4, "fiftyDayAverage": 0.117042, "twoHundredDayAverage": 0.1794904, "currency": "USD", "enterpriseValue": 13775620, "floatShares": 51829656, "sharesOutstanding": 93540096, "sharesShort": 2033620, "sharesShortPriorMonth": 2078231, "sharesShortPreviousMonthDate": 1684108800, "dateShortInterest": 1686787200, "sharesPercentSharesOut": 0.0223, "heldPercentInsiders": 0.44634, "heldPercentInstitutions": 0.0014, "shortRatio": 59.74, "shortPercentOfFloat": 0.0465, "impliedSharesOutstanding": 93540096, "bookValue": -0.034, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1703980800, "netIncomeToCommon": -8844000, "trailingEps": -0.1, "enterpriseToEbitda": -1.652, "52WeekChange": -0.8227848, "SandP52WeekChange": 0.31426477, "exchange": "PNK", "quoteType": "EQUITY", "symbol": "NYMXF", "underlyingSymbol": "NYMXF", "shortName": "Nymox Pharmaceutical Corp.", "longName": "Nymox Pharmaceutical Corporation", "firstTradeDateEpochUtc": 880554600, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EST", "uuid": "dd6b02d8-6181-3ff0-ba49-97b4bbaf6014", "messageBoardId": "finmb_389645", "gmtOffSetMilliseconds": -18000000, "currentPrice": 0.14, "recommendationKey": "none", "totalCash": 70000, "totalCashPerShare": 0.001, "ebitda": -8339000, "totalDebt": 750000, "quickRatio": 0.021, "currentRatio": 0.164, "returnOnAssets": -4.63477, "freeCashflow": -1118875, "operatingCashflow": -4057000, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-12-07"}]